Keratoacanthoma
Skin
Skin Diseases
Skin Aging
Pancreatic Neoplasms
Neoplasms
Dictionaries, Medical
Malignant Atrophic Papulosis
Activation of telomerase and its association with G1-phase of the cell cycle during UVB-induced skin tumorigenesis in SKH-1 hairless mouse. (1/10127)
Telomerase is a ribonucleoprotein enzyme that adds hexanucleotide repeats TTAGGG to the ends of chromosomes. Telomerase activation is known to play a crucial role in cell-immortalization and carcinogenesis. Telomerase is shown to have a correlation with cell cycle progression, which is controlled by the regulation of cyclins, cyclin dependent kinases (cdks) and cyclin dependent kinase inhibitors (cdkis). Abnormal expression of these regulatory molecules may cause alterations in cell cycle with uncontrolled cell growth, a universal feature of neoplasia. Skin cancer is the most prevalent form of cancer in humans and the solar UV radiation is its major cause. Here, we investigated modulation in telomerase activity and protein expression of cell cycle regulatory molecules during the development of UVB-induced tumors in SKH-1 hairless mice. The mice were exposed to 180 mjoules/cm2 UVB radiation, thrice weekly for 24 weeks. The animals were sacrificed at 4 week intervals and the studies were performed in epidermis. Telomerase activity was barely detectable in the epidermis of non-irradiated mouse. UVB exposure resulted in a progressive increase in telomerase activity starting from the 4th week of exposure. The increased telomerase activity either persisted or further increased with the increased exposure. In papillomas and carcinomas the enzyme activity was comparable and was 45-fold higher than in the epidermis of control mice. Western blot analysis showed an upregulation in the protein expression of cyclin D1 and cyclin E and their regulatory subunits cdk4 and cdk2 during the course of UVB exposure and in papillomas and carcinomas. The protein expression of cdk6 and ckis viz. p16/Ink4A, p21/Waf1 and p27/Kip1 did not show any significant change in UVB exposed skin, but significant upregulation was observed both in papillomas and carcinomas. The results suggest that telomerase activation may be involved in UVB-induced tumorigenesis in mouse skin and that increased telomerase activity may be associated with G1 phase of the cell cycle. (+info)L-[1-11C]-tyrosine PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma and skin cancer. (2/10127)
PET with L-[1-11C]-tyrosine (TYR) was investigated in patients undergoing hyperthermic isolated limb perfusion (HILP) with recombinant tumor necrosis factor alpha (rTNF-alpha) and melphalan for locally advanced soft-tissue sarcoma and skin cancer of the lower limb. METHODS: Seventeen patients (5 women, 12 men; age range 24-75 y; mean age 52 y) were studied. TYR PET studies were performed before HILP and 2 and 8 wk afterwards. The protein synthesis rates (PSRs) in nanomoles per milliliter per minute were calculated. After final PET studies, tumors were resected and pathologically examined. Patients with pathologically complete responses (pCR) showed no viable tumors after treatment. Those with pathologically partial responses (pPR) showed various amounts of viable tumors in the resected tumor specimens. RESULTS: Six patients (35%) showed a pCR and 11 patients (65%) showed a pPR. All tumors were depicted as hot spots on PET studies before HILP. The PSR in the pCR group at 2 and 8 wk after perfusion had decreased significantly (P < 0.05) in comparison to the PSR before HILP. A significant difference was found in PSR between the pCR and pPR groups at 2 and at 8 wk (P < 0.05). Median PSR in nonviable tumor tissue was 0.62 and ranged from 0.22 to 0.91. With a threshold PSR of 0.91, sensitivity and specificity of TYR PET were 82% and 100%, respectively. The predictive value of a PSR > 0.91 for having viable tumor after HILP was 100%, whereas the predictive value of a PSR < or = 0.91 for having nonviable tumor tissue after HILP was 75%. The 2 patients in the pPR groups with a PSR < 0.91 showed microscopic islets of tumor cells surrounded by extensive necrosis on pathological examination. CONCLUSION: Based on the calculated PSR after HILP, TYR PET gave a good indication of the pathological outcome. Inflammatory tissue after treatment did not interfere with viable tumor on the images, suggesting that it may be worthwhile to pursue TYR PET in other therapy evaluation settings. (+info)Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma. (3/10127)
Beta-Catenin has a critical role in E-cadherin-mediated cell-cell adhesion, and it also functions as a downstream signaling molecule in the wnt pathway. Mutations in the putative glycogen synthase kinase 3beta phosphorylation sites near the beta-catenin amino terminus have been found in some cancers and cancer cell lines. The mutations render beta-catenin resistant to regulation by a complex containing the glycogen synthase kinase 3beta, adenomatous polyposis coli, and axin proteins. As a result, beta-catenin accumulates in the cytosol and nucleus and activates T-cell factor/ lymphoid enhancing factor transcription factors. Previously, 6 of 27 melanoma cell lines were found to have beta-catenin exon 3 mutations affecting the N-terminal phosphorylation sites (Rubinfeld B, Robbins P, Elgamil M, Albert I, Porfiri E, Polakis P: Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 1997, 275:1790-1792). To assess the role of beta-catenin defects in primary melanomas, we undertook immunohistochemical and DNA sequencing studies in 65 melanoma specimens. Nuclear and/or cytoplasmic localization of beta-catenin, a potential indicator of wnt pathway activation, was seen focally within roughly one third of the tumors, though a clonal somatic mutation in beta-catenin was found in only one case (codon 45 Ser-->Pro). Our findings demonstrate that beta-catenin mutations are rare in primary melanoma, in contrast to the situation in melanoma cell lines. Nonetheless, activation of beta-catenin, as indicated by its nuclear and/or cytoplasmic localization, appears to be frequent in melanoma, and in some cases, it may reflect focal and transient activation of the wnt pathway within the tumor. (+info)Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. (4/10127)
Dendritic cells (DC) are critically involved in the initiation of primary immune processes, including tumor rejection. In our study, we investigated the effect of interleukin-10 (IL-10)-treated human DC on the properties of CD8(+) T cells that are known to be essential for the destruction of tumor cells. We show that IL-10-pretreatment of DC not only reduces their allostimulatory capacity, but also induces a state of alloantigen-specific anergy in both primed and naive (CD45RA+) CD8(+) T cells. To investigate the influence of IL-10-treated DC on melanoma-associated antigen-specific T cells, we generated a tyrosinase-specific CD8(+) T-cell line by several rounds of stimulation with the specific antigen. After coculture with IL-10-treated DC, restimulation of the T-cell line with untreated, antigen-pulsed DC demonstrated peptide-specific anergy in the tyrosinase-specific T cells. Addition of IL-2 to the anergic T cells reversed the state of both alloantigen- or peptide-specific anergy. In contrast to optimally stimulated CD8(+) T cells, anergic tyrosinase-specific CD8(+) T cells, after coculture with peptide-pulsed IL-10-treated DC, failed to lyse an HLA-A2-positive and tyrosinase-expressing melanoma cell line. Thus, our data demonstrate that IL-10-treated DC induce an antigen-specific anergy in cytotoxic CD8(+) T cells, a process that might be a mechanism of tumors to inhibit immune surveillance by converting DC into tolerogenic antigen-presenting cells. (+info)Gardner's syndrome and steatocystoma multiplex. Two unusual genetically determined conditions occurring in same patient. (5/10127)
A 43-year-old man is described who had Gardner's syndrome and steatocystoma multiplex. These two unusual genetically determined conditions were associated because he had inherited the Gardner's syndrome from his father and the steatocystoma multiplex from his mother. (+info)MDM2 overexpression generates a skin phenotype in both wild type and p53 null mice. (6/10127)
The MDM2 proto-oncogene is overexpressed in human tumours and regulates the activities of the tumour suppressors p53 and pRB. We created mice that overexpress MDM2 under the control of the CMV promoter. These mice did not display an increased tumour incidence, but rather a specific skin phenotype, characterized by desquamation and hyperkeratosis. Transgenic MDM2 was found to be overexpressed in the epidermis, a tissue that normally expresses high levels of MDM2. The phenotype appeared during the first week after birth and then lessened with age, closely following the level of expression of the transgene. MDM2 overexpression was associated with an increase in proliferation in the basal layer, thickening of the epidermis, altered expression of the differentiation markers cytokeratin CK14, CK10 and CK1, and a decrease in the size and the number of granules that contain products of differentiation. Transgenic mice on a p53 null background displayed similar although not identical changes, showing that the effects of MDM2 are to a certain degree p53 independent. The skin is a major site of MDM2 expression in mice, raising the possibility that MDM2 overexpression perturbs the normal pattern of MDM2 expression and inhibits differentiation of the epidermis. (+info)Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization. (7/10127)
The development of skin carcinomas presently is believed to be correlated with mutations in the p53 tumor suppressor and ras gene as well as with the loss of chromosome 9. We now demonstrate that, in addition, loss of chromosome 15 may be a relevant genetic defect. Reintroduction of an extra copy of chromosome 15, but not chromosome 4, into the human skin carcinoma SCL-I cells, lacking one copy of each chromosome, resulted in tumor suppression after s.c. injection in mice. Transfection with thrombospondin-1 (TSP-1), mapped to 15q15, induced the same tumor suppression without affecting cell proliferation in vitro or in vivo. Halted tumors remained as small cysts encapsulated by surrounding stroma and blood vessels. These cysts were characterized by increased TSP-1 matrix deposition at the tumor/stroma border and a complete lack of tumor vascularization. Coinjection of TSP-1 antisense oligonucleotides drastically reduced TSP-1 expression and almost completely abolished matrix deposition at the tumor/stroma border. As a consequence, the tumor phenotype reverted to a well vascularized, progressively expanding, solid carcinoma indistinguishable from that induced by the untransfected SCL-I cells. Thus, these data strongly suggest TSP-1 as a potential tumor suppressor on chromosome 15. The data further propose an unexpected mechanism of TSP-1-mediated tumor suppression. Instead of interfering with angiogenesis in general, in this system TSP-1 acts as a matrix barrier at the tumor/stroma border, which, by halting tumor vascularization, prevents tumor cell invasion and, thus, tumor expansion. (+info)Glucocorticoid mediation of dietary energy restriction inhibition of mouse skin carcinogenesis. (8/10127)
Dietary energy restriction (DER) inhibits carcinogenesis in numerous animal models. DER is a potent and reproducible inhibitor of two-stage mouse skin carcinogenesis when administered during the promotion phase. Previous research demonstrated that adrenalectomy abolished cancer prevention by food restriction. Several lines of evidence suggest that glucocorticoid elevation in the DER mouse mediates the prevention of skin cancer. Our research tested the hypothesis that elevated glucocorticoid hormone activates the glucocorticoid receptor (GR) and that this activated receptor interferes with the activator protein-1 (AP-1) transcription factor. Induction of AP-1 by the phorbol ester tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) is essential to tumor promotion. We have been unable to demonstrate elevated activated GR in the epidermis of the DER mouse, perhaps because only indirect strategies have been possible with the use of epidermis from DER mice. However, DER blocked the induction of AP-1 and c-jun, a constituent protein of AP-1, in the epidermis of mice. Current studies are focused on the inhibition of signaling down the MAP-1/Raf-1 kinase pathway that leads to induction of constituent proteins of AP-1, including c-Jun. Although several pathways lead to the induction of AP-1 transcriptional activity, the MAP-1/Raf-1 pathway can be activated by protein kinase C (PKC); previous studies from our laboratory demonstrated an inhibition of PKC activity and a reduction in selected isoforms of PKC in the epidermis of the DER mouse. Our current working hypothesis is that elevated glucocorticoid hormone in the DER mouse reduces the amount and activity of PKC isoforms important in the activation of MAP-1/Raf-1 kinase pathway. We propose that this results in attenuation in the induction of the AP-1 transcription factor by TPA. Because AP-1 induction by TPA is obligatory for mouse skin promotion, we propose this as an essential component of the mechanism of DER prevention of mouse skin carcinogenesis. (+info)Keratoacanthoma is a rapidly growing, dome-shaped, skin tumor that typically arises on sun-exposed areas such as the face, arms, and legs. It is considered a low-grade squamous cell carcinoma (a type of skin cancer) because it shares some characteristics with both benign and malignant tumors.
Keratoacanthomas usually develop over a period of several weeks to months, growing rapidly in size before eventually stabilizing and then gradually regressing on their own within a few months to a year. However, the regression process can take years, and some lesions may not regress completely, leading to cosmetic concerns or even local invasion.
Histologically, keratoacanthomas are characterized by a central keratin-filled crater surrounded by a well-differentiated layer of squamous epithelial cells. The tumor's growth pattern and histological features can make it difficult to distinguish from other types of skin cancer, such as squamous cell carcinoma.
Treatment options for keratoacanthomas include surgical excision, cryosurgery, curettage and electrodesiccation, and topical therapies like imiquimod or 5-fluorouracil. The choice of treatment depends on various factors such as the size, location, and number of lesions, as well as patient preferences and overall health status.
Skin neoplasms refer to abnormal growths or tumors in the skin that can be benign (non-cancerous) or malignant (cancerous). They result from uncontrolled multiplication of skin cells, which can form various types of lesions. These growths may appear as lumps, bumps, sores, patches, or discolored areas on the skin.
Benign skin neoplasms include conditions such as moles, warts, and seborrheic keratoses, while malignant skin neoplasms are primarily classified into melanoma, squamous cell carcinoma, and basal cell carcinoma. These three types of cancerous skin growths are collectively known as non-melanoma skin cancers (NMSCs). Melanoma is the most aggressive and dangerous form of skin cancer, while NMSCs tend to be less invasive but more common.
It's essential to monitor any changes in existing skin lesions or the appearance of new growths and consult a healthcare professional for proper evaluation and treatment if needed.
In medical terms, the skin is the largest organ of the human body. It consists of two main layers: the epidermis (outer layer) and dermis (inner layer), as well as accessory structures like hair follicles, sweat glands, and oil glands. The skin plays a crucial role in protecting us from external factors such as bacteria, viruses, and environmental hazards, while also regulating body temperature and enabling the sense of touch.
Skin diseases, also known as dermatological conditions, refer to any medical condition that affects the skin, which is the largest organ of the human body. These diseases can affect the skin's function, appearance, or overall health. They can be caused by various factors, including genetics, infections, allergies, environmental factors, and aging.
Skin diseases can present in many different forms, such as rashes, blisters, sores, discolorations, growths, or changes in texture. Some common examples of skin diseases include acne, eczema, psoriasis, dermatitis, fungal infections, viral infections, bacterial infections, and skin cancer.
The symptoms and severity of skin diseases can vary widely depending on the specific condition and individual factors. Some skin diseases are mild and can be treated with over-the-counter medications or topical creams, while others may require more intensive treatments such as prescription medications, light therapy, or even surgery.
It is important to seek medical attention if you experience any unusual or persistent changes in your skin, as some skin diseases can be serious or indicative of other underlying health conditions. A dermatologist is a medical doctor who specializes in the diagnosis and treatment of skin diseases.
Skin aging, also known as cutaneous aging, is a complex and multifactorial process characterized by various visible changes in the skin's appearance and function. It can be divided into two main types: intrinsic (chronological or natural) aging and extrinsic (environmental) aging.
Intrinsic aging is a genetically determined and time-dependent process that results from internal factors such as cellular metabolism, hormonal changes, and genetic predisposition. The primary features of intrinsic aging include gradual thinning of the epidermis and dermis, decreased collagen and elastin production, reduced skin cell turnover, and impaired wound healing. Clinically, these changes present as fine wrinkles, dryness, loss of elasticity, and increased fragility of the skin.
Extrinsic aging, on the other hand, is caused by external factors such as ultraviolet (UV) radiation, pollution, smoking, alcohol consumption, and poor nutrition. Exposure to these environmental elements leads to oxidative stress, inflammation, and DNA damage, which accelerate the aging process. The main features of extrinsic aging are coarse wrinkles, pigmentary changes (e.g., age spots, melasma), irregular texture, skin laxity, and increased risk of developing skin cancers.
It is important to note that intrinsic and extrinsic aging processes often interact and contribute to the overall appearance of aged skin. A comprehensive approach to skincare should address both types of aging to maintain healthy and youthful-looking skin.
Pancreatic neoplasms refer to abnormal growths in the pancreas that can be benign or malignant. The pancreas is a gland located behind the stomach that produces hormones and digestive enzymes. Pancreatic neoplasms can interfere with the normal functioning of the pancreas, leading to various health complications.
Benign pancreatic neoplasms are non-cancerous growths that do not spread to other parts of the body. They are usually removed through surgery to prevent any potential complications, such as blocking the bile duct or causing pain.
Malignant pancreatic neoplasms, also known as pancreatic cancer, are cancerous growths that can invade and destroy surrounding tissues and organs. They can also spread (metastasize) to other parts of the body, such as the liver, lungs, or bones. Pancreatic cancer is often aggressive and difficult to treat, with a poor prognosis.
There are several types of pancreatic neoplasms, including adenocarcinomas, neuroendocrine tumors, solid pseudopapillary neoplasms, and cystic neoplasms. The specific type of neoplasm is determined through various diagnostic tests, such as imaging studies, biopsies, and blood tests. Treatment options depend on the type, stage, and location of the neoplasm, as well as the patient's overall health and preferences.
Neoplasms are abnormal growths of cells or tissues in the body that serve no physiological function. They can be benign (non-cancerous) or malignant (cancerous). Benign neoplasms are typically slow growing and do not spread to other parts of the body, while malignant neoplasms are aggressive, invasive, and can metastasize to distant sites.
Neoplasms occur when there is a dysregulation in the normal process of cell division and differentiation, leading to uncontrolled growth and accumulation of cells. This can result from genetic mutations or other factors such as viral infections, environmental exposures, or hormonal imbalances.
Neoplasms can develop in any organ or tissue of the body and can cause various symptoms depending on their size, location, and type. Treatment options for neoplasms include surgery, radiation therapy, chemotherapy, immunotherapy, and targeted therapy, among others.
An acanthoma is a benign skin tumor characterized by the proliferation of epidermal cells, specifically the pickle cell layer (stratum spinosum). The term "acanthoma" comes from the Greek word "akantha," which means "thorn" or "spine."
There are several types of acanthomas, including:
1. Seborrheic keratosis: Also known as seborrheic warts, these are common benign growths that appear as rough, scaly patches on the skin. They can be tan, brown, or black and may have a waxy or greasy appearance.
2. Benign lichenoid keratosis: These are small, flat lesions with a scaly surface that typically occur on sun-exposed areas of the skin. They are usually asymptomatic but may occasionally itch.
3. Psoriasiform acanthoma: This is a rare type of acanthoma that resembles psoriasis, a chronic skin condition characterized by red, scaly patches.
4. Clear cell acanthoma: This is a distinctive type of acanthoma that appears as a solitary, dome-shaped nodule with a smooth surface and a central crust. It typically occurs on the lower legs of older adults.
Acanthomas are generally harmless and do not require treatment unless they become irritated or unsightly. In such cases, they can be removed through various methods, including cryosurgery (freezing), curettage (scraping), or excision (cutting).
A medical dictionary is a reference book that contains definitions and explanations of medical terms and jargon. It serves as a useful tool for healthcare professionals, students, patients, and anyone else who needs to understand medical terminology. Medical dictionaries can include definitions of diseases, conditions, treatments, procedures, drugs, equipment, anatomy, and more. They may also provide pronunciation guides, etymologies, and abbreviations.
Medical dictionaries can be found in print or digital form, and some are specialized to cover specific areas of medicine, such as oncology, psychiatry, or surgery. Some medical dictionaries are also bilingual, providing translations of medical terms between different languages. Overall, a medical dictionary is an essential resource for anyone who needs to communicate effectively in the field of medicine.
Malignant atrophic papulosis (MAP), also known as Kohlmeier-Degos disease, is a rare and progressive cutaneous vasculopathy of unknown etiology. It is characterized by the development of porcelain-white atrophic macules, which evolve into papules with a central necrotic depression or ulceration, surrounded by an erythematous halo. The lesions typically appear on the trunk and extremities, but may also affect mucous membranes, gastrointestinal tract, and other organs.
MAP is considered to be a chronic inflammatory disorder that affects small-sized blood vessels, leading to tissue ischemia and necrosis. The disease can have a variable clinical course, ranging from self-limited cutaneous involvement to systemic manifestations with potentially life-threatening complications.
The diagnosis of MAP is based on the clinical presentation, histopathological findings, and exclusion of other similar conditions. Treatment options for MAP are limited, and there is no cure for this disease. The management typically involves a multidisciplinary approach to address the various organ manifestations and prevent complications.
An encyclopedia is a comprehensive reference work containing articles on various topics, usually arranged in alphabetical order. In the context of medicine, a medical encyclopedia is a collection of articles that provide information about a wide range of medical topics, including diseases and conditions, treatments, tests, procedures, and anatomy and physiology. Medical encyclopedias may be published in print or electronic formats and are often used as a starting point for researching medical topics. They can provide reliable and accurate information on medical subjects, making them useful resources for healthcare professionals, students, and patients alike. Some well-known examples of medical encyclopedias include the Merck Manual and the Stedman's Medical Dictionary.
Acanthoma
Mouse model of colorectal and intestinal cancer
Human skin
Hidradenoma
Skin condition
Malignant chondroid syringoma
Trichoepithelioma
Pathology
Trichoblastoma
Extramammary Paget's disease
CYLD cutaneous syndrome
Spiradenoma
Eumycetoma
Skin cancer in horses
Corticosteroid
Laugier-Hunziker syndrome
Nevus spilus
Sebaceous carcinoma
Neoplasms of the nailbed
Dysplastic nevus syndrome
Carney complex
List of skin conditions
List of MeSH codes (C04)
Rombo syndrome
Comorbidity
Liver spot
List of ICD-9 codes 140-239: neoplasms
STK11
Oral pigmentation
Neoplasm
Information for Benign neoplasm of skin
Mesenchymal Neoplasms Affecting the Skin and Subcutaneous Tissues in the Dog and Cat<...
Skin Diseases - Skin Neoplasms | CU Experts | CU Boulder
Skin, benign neoplasm - CCMDB Wiki
Sentinel Lymph Node Biopsy in Nonmelanoma Skin Cancer Patients
Pathology of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Overview, Definition and Epidemiology, Clinical Features
Malignant neoplasm of skin (Concept Id: C0007114) - MedGen - NCBI
October 1976 - Volume 58 - Issue 4 : Plastic and Reconstructive Surgery
Skin Cancer Types (Nonmelanoma) | Moffitt
Skin Cancer | Basal Cell Carcinoma | MedlinePlus
ICD-10 Code for Malignant neoplasm of external lower lip- C00.1- Codify by AAPC
A case of blastic plasmacytoid dendritic cell neoplasm involving the skin<...
Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4...
38 CFR § 4.118 - Schedule of ratings-skin. | Electronic Code of Federal Regulations (e-CFR) | US Law | LII / Legal Information...
Acanthoma - Wikipedia
Imiquimod induced regression of clinically diagnosed superficial basal cell carcinoma is associated with early infiltration by...
A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma
Maraviroc: Package Insert - Drugs.com
Regulations - WTC Health Program
RXQ RX H
Spencer Wells (Author of The Journey of Man)
Nonmelanoma Skin Cancer- Epidemiology Forecast to 2032
Advanced Search Results - Public Health Image Library(PHIL)
Glatopa (glatiramer acetate Injection): Uses, Dosage, Side Effects, Interactions, Warning
The EPA National Library Catalog | EPA National Library Network | US EPA
Dermatologic Surgery and Cutaneous Oncology | Dermatology
Connie Rong Shi, M.D. | Harvard Catalyst Profiles | Harvard Catalyst
Biblio | Page 9 | Linus Pauling Institute | Oregon State University
Christine Ko, MD | Yale School of Medicine
Melanoma15
- Pathology of the skin in cutaneous melanoma. (nih.gov)
- Another type of skin cancer, melanoma , is more dangerous but less common. (medlineplus.gov)
- There was no obvious difference in the biodistribution of (I) and (IV) in relation to the site of the melanoma growth, i.e. eyes and skin. (curehunter.com)
- HCM-BROD-0221-C43 ( ATCC PDM-281 ) was isolated from metastatic melanoma of skin tissue. (atcc.org)
- Sylatron is a prescription medication used to prevent malignant melanoma (a kind of skin cancer ) from coming back after it has been removed by surgery. (rxwiki.com)
- Skin cancer, commonly classified as either melanoma or non-melanoma skin cancer (NMSC), is the most common type of cancer in Canada. (canada.ca)
- Footnote 1 The incidence of melanoma, the most fatal form of skin cancer, is increasing steadily-2.1% in males and 2.0% in females Footnote 1 , Footnote 2 every year between 1992 and 2013. (canada.ca)
- The risk of skin cancer due to indoor tanning is especially pronounced if first use occurs at an early age: there is a 59% higher risk of cutaneous melanoma among people who begin using indoor tanning devices before the age of 35 than among those who have never used tanning beds. (canada.ca)
- Footnote 3 The use of these devices before the age of 25 can also increase the risk of developing non-melanoma skin cancer, including basal cell carcinoma and squamous cell carcinoma. (canada.ca)
- The term non-melanoma skin cancer refers to all types of skin cancer apart from melanoma. (dermnetnz.org)
- A partial skin biopsy may be taken in cases of suspected non-melanoma skin cancer to confirm the diagnosis or determine a subtype which may influence treatment. (dermnetnz.org)
- The three most common malignant skin cancers are basal cell cancer, squamous cell cancer, and melanoma, each of which is named after the type of skin cell from which it arises. (medicalxpress.com)
- Melanoma survival rates are poorer than for non-melanoma skin cancer, although when melanoma is diagnosed at an early stage, treatment is easier and more people survive. (medicalxpress.com)
- Melanoma and non-melanoma skin cancers combined are more common than lung, breast, colorectal, and prostate cancer. (medicalxpress.com)
- Non-melanoma skin cancers are the most common skin cancers. (medicalxpress.com)
Cutaneous7
- The neoplastic cells in blastic plasmacytoid dendritic cell neoplasm (BPDCN) are typically positive for CD45, HLA-DR, CD43, CD4, CD56, and cutaneous lymphocyte-associated antigen (CLA). (medscape.com)
- We report nine cases of persistent/recurrent cutaneous CD30+ lymphoid neoplasms that demonstrated variable CD30 expression after treatment with brentuximab vedotin. (nih.gov)
- Next, co-exposure studies (combining topical HOCl and UV) performed in SKH-1 hairless mouse skin revealed that the HOCl-induced cutaneous stress response blocks redox and inflammatory gene expression elicited by subsequent acute UV exposure (Nos2, Ptgs2, Hmox1, Srxn1), a finding consistent with emerging clinical evidence in support of a therapeutic role of topical HOCl formulations for the suppression of inflammatory skin conditions (e.g. atopic dermatitis, psoriasis). (nih.gov)
- Intertrigo is caused by cutaneous inflammation of opposing skin surfaces. (aafp.org)
- Footnote 2 Exposure to ultraviolet (UV) radiation, including that from tanning equipment, has been demonstrated to increase the risk of skin cancer, including potentially fatal cutaneous and ocular melanomas. (canada.ca)
- Agranular CD4+/CD56+ hematodermic neoplasm is a distinct form of lymphoma with aggressive behavior and marked predilection for cutaneous involvement. (mcmaster.ca)
- Human papillomaviruses (HPVs) are etiologically associated with various benign and malignant neoplasms of cutaneous and mucosal epithelia. (mdpi.com)
Tumors7
- Tumors or cancer of the SKIN. (selfdecode.com)
- Following craniospinal irradiation in children with medulloblastoma, secondary neoplasms are among the most serious long-term sequelae that include leukemias and solid tumors of the urinary or digestive tracts, thyroid, skin, and central nervous system. (amjcaserep.com)
- Metachronous of development of 4 histopathologically different skin tumors following craniospinal irradiation for medulloblastoma in long-term survivors has not previously been reported. (amjcaserep.com)
- They are not true neoplasms ( tumors ), but they are invasive, spreading into nearby tissue. (ivis.org)
- 2017. Divergent roles of p120-catenin isoforms linked to altered cell viability, proliferation, and invasiveness in carcinogen-induced rat skin tumors. . (oregonstate.edu)
- The skin rash of mycosis fungoides may consist of patches, plaques, or tumors, which may have a long natural history. (medscape.com)
- For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. (icdcodelookup.com)
Malignant Skin Neoplasms1
- The development of malignant skin neoplasms in PLS patients is extremely rare. (karger.com)
Table of Neoplasms2
- See also, ICD-10 Table of Neoplasms . (icd10coded.com)
- The Table of Neoplasms should be used to identify the correct topography code. (icdcodelookup.com)
Benign Neoplasms1
- Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms . (lookformedical.com)
Plasmacytoid dend6
- Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a malignancy derived from plasmacyoid dendritic cells. (medscape.com)
- The precursors of plasmacytoid dendritic cells are the cells of origin for blastic plasmacytoid dendritic cell neoplasm (BPDCN), a clinically aggressive disease with a proclivity for the skin and leukemic involvement and for which no consensus currently exists regarding optimal treatment modalities. (medscape.com)
- Frequent sites of occurrence of blastic plasmacytoid dendritic cell neoplasm (BPDCN) include the skin, as well as the peripheral blood (PB) and bone marrow (BM). (medscape.com)
- A diffuse infiltrate of medium-sized cells with dispersed chromatin ("blastic") is characteristic of blastic plasmacytoid dendritic cell neoplasm (BPDCN). (medscape.com)
- Pathology of blastic plasmacytoid dendritic cell neoplasm (BPDCN).Skin involvement by blastic plasmacytoid dendritic cell neoplasm. (medscape.com)
- In the recent World Health Organization-European Organization for Research and Treatment of Cancer classification, the term blastic natural killer cell lymphoma has been replaced with CD4+/CD56+ hematodermic neoplasm because of its derivation from a plasmacytoid dendritic cell precursor. (mcmaster.ca)
Carcinoma2
- The development of aggressive squamous cell carcinoma (SCC) in areas of affected skin is a distinctive feature of the syndrome, occurring in approximately 15% of patients. (mcw.edu)
- Basal cell carcinoma (BCC) is a malignant epithelial neoplasm and is the most common cancer in the head and neck region. (who.int)
Lesions2
- A Congenital Nevocytic Nevus Registry has been established in the Oncology Section of the Skin and Cancer Unit at New York University Medical Center in the attempt to begin a long-term prospective study which might eventually provide some meaningful information concerning the natural history of such lesions, including the incidence of malignant melanomas. (nih.gov)
- Early in the course of mycosis fungoides, as well as in erythrodermic cases, the skin lesions may be nonspecific, with a nondiagnostic biopsy result, so that confusion with benign conditions is common (eg, eczema, neurodermatitis, pseudolymphoma syndrome). (medscape.com)
Squamous Cell1
- What's New in Basal and Squamous Cell Skin Cancer Research? (medlineplus.gov)
Cancer23
- Skin cancer is the most common form of cancer in the United States. (medlineplus.gov)
- If not treated, some types of skin cancer cells can spread to other tissues and organs. (medlineplus.gov)
- What Can I Do to Reduce My Risk of Skin Cancer? (medlineplus.gov)
- Our findings suggest that many children are at subsequent risk of skin cancer because of suboptimal sunscreen use, high rates of sunburning, and tanning bed use. (nih.gov)
- Nationally coordinated campaigns with strong policy components must be developed and sustained to prevent skin cancer in a new generation of children and adolescents. (nih.gov)
- Since this is not the first case of skin cancer in PLS patients, we are supporting the possibility that cathepsin-C play a role in cancer development. (karger.com)
- Legislative gaps should be addressed in order to better protect Canadians from this avoidable skin cancer risk. (canada.ca)
- Each subtype of skin cancer has unique characteristics. (dermnetnz.org)
- Many different types of less common skin cancer are listed in the related information section at the bottom of this page. (dermnetnz.org)
- Who gets skin cancer? (dermnetnz.org)
- Skin cancer most commonly affects older adults, but it can also affect younger adults, and rarely, children. (dermnetnz.org)
- Skin cancer tends to affect individuals with fair skin ( Fitzpatrick skin phototype I, II and III), although people with darker skin can also develop skin cancer. (dermnetnz.org)
- People who have had skin cancer have an increased risk of developing other skin cancers. (dermnetnz.org)
- A family history of skin cancer also increases risk. (dermnetnz.org)
- Certain genes such as melanocortin-1 receptor have been identified as carrying an increased risk of skin cancer. (dermnetnz.org)
- The common forms of skin cancer listed above are related to exposure to ultraviolet radiation (from sunlight or tanning beds ) and the effects of ageing. (dermnetnz.org)
- What are the clinical features of skin cancer? (dermnetnz.org)
- Skin cancer can usually be treated and cured before complications occur. (dermnetnz.org)
- How is skin cancer diagnosed? (dermnetnz.org)
- Clinicopathologic features, immunohistochemical features, and differential diagnosis of this rare neoplasm with emphasis on the recent World Health Organization-European Organization for Research and Treatment of Cancer classification are discussed. (mcmaster.ca)
- Skin neoplasms (also known as " skin cancer ") are skin growths with differing causes and varying degrees of malignancy. (medicalxpress.com)
- Skin cancer generally develops in the epidermis (the outermost layer of skin), so a tumor can usually be seen. (medicalxpress.com)
- Skin cancer is the most commonly diagnosed type of cancer. (medicalxpress.com)
Syndromes1
- Genetics of skin appendage neoplasms and related syndromes. (dermnetnz.org)
Acanthoma1
- An acanthoma is a skin neoplasm composed of squamous or epidermal cells. (wikipedia.org)
Tumour2
- The tumour is most common on those parts of the skin exposed to sunlight, which is thought to be a possible etiological factor [1]. (who.int)
- Brooke-Spiegler syndrome results in a predisposition to three types of benign skin appendage tumour. (dermnetnz.org)
Biopsy1
- Therefore skin biopsy is required to confirm the diagnosis. (dermnetnz.org)
Cancers5
- The keystone of the program is a technique known as Microscopically Controlled Excision (Mohs Technique, applied specifically for recurrent or other high-risk skin cancers. (yale.edu)
- Sophisticated approaches for the management of other complicated or rare skin cancers are also provided. (yale.edu)
- Skin cancers are malignant tumours in which there is an uncontrolled proliferation of any one of the many skin cell types, whereas the normal process of regeneration of skin involves replication of the cells in a controlled fashion. (dermnetnz.org)
- Skin cancers are generally diagnosed clinically by a dermatologist or family doctor, when learning of an enlarging, crusting , or bleeding lesion. (dermnetnz.org)
- This means that it is often possible to detect skin cancers at an early stage. (medicalxpress.com)
Melanocytic3
- Melanocytic Skin Neoplasms: What Lesson From Genomic Aberrations? (nih.gov)
- Studies on the genomic aberrations in melanocytic neoplasms have shown a complex genomic landscape. (nih.gov)
- In this context, the notion that melanocytic neoplasms can be classified as benign/malignant is hardly supportable, because all neoplasms harbor a certain number of mutations and the progression risk, that is, the malignant potential, is related and proportional to the burden of pathogenic mutations. (nih.gov)
Uncommon2
- Acquired digital fibrokeratoma (ADF), or acral fibrokeratoma, is an uncommon, benign neoplasm that presents as a solitary asymptomatic papule on the digit (finger or toe), nail bed, or periungual area of middle-aged adults. (logicalimages.com)
- DFSP is an uncommon neoplasm with low metastatic potential, carrying a 2%-5% risk of distant metastasis. (logicalimages.com)
Epidermis1
- Here, for the first time, we have profiled the HOCl-induced stress response in reconstructed human epidermis and SKH-1 hairless mouse skin. (nih.gov)
Tumor1
- Fifteen years later, she developed a primary adnexal tumor at the medial aspect of her left thigh, glomangioma at the skin of her upper abdomen, dermatofibrosarcoma protruberans at the skin of her upper back, and Kaposiform hemangioendothelioma of the upper abdomen. (amjcaserep.com)
Diagnosis2
- The median duration from the onset of skin symptoms to diagnosis is 6 years. (medscape.com)
- C63.7 is a valid billable ICD-10 diagnosis code for Malignant neoplasm of other specified male genital organs . (icd10coded.com)
Chronic1
- Intertrigo is often a chronic disorder that begins insidiously with the onset of pruritus, stinging, and a burning sensation in skin folds. (aafp.org)
Primary2
- Skin-testing with flea extracts is not as reliable as in the dog and the therapeutic response to a thorough flea-control of the animals and the environment is of primary importance. (vin.com)
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. (icdcodelookup.com)
Chapter2
- All neoplasms are classified in this chapter, whether they are functionally active or not. (icdcodelookup.com)
- An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. (icdcodelookup.com)
Tissue4
- We will obtain tissue (skin, blood, hair, buccal swabs) for laboratory examination of DNA repair and for genetic analysis. (nih.gov)
- Inability or unwillingness to provide tissue (skin, blood, buccal cells or hair) for laboratory studies. (nih.gov)
- 17,18 Therapy usually includes surgical resection, although with diffuse tissue involvement there may be an insufficient amount of normal skin to close the wound. (ivis.org)
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9). (icdcodelookup.com)
Symptoms2
- Immediately discontinue maraviroc and other suspected agents if signs or symptoms of severe skin or hypersensitivity reactions develop and monitor clinical status, including liver aminotransferases, closely. (nih.gov)
- Symptoms of thyroid changes include feeling cold or hot all the time, a change in your weight, and changes to your skin, trouble concentrating. (rxwiki.com)
Epidermal1
- BCC of the skin is generally believed to arise from the basal cell layer of the epithelium associated with epidermal adnexal structures. (who.int)
Arises1
- A non-metastasizing neoplasm that arises from the skin. (nih.gov)
Recurrent2
- This study seeks to assess for antigen loss in the setting of recurrent CD30+ neoplasms treated with brentuximab vedotin. (nih.gov)
- Skin barrier protectants, such as zinc oxide ointment and petrolatum, as part of a structured skin care routine that also includes gentle cleansing and moisturizing may reduce recurrent intertrigo infections. (aafp.org)
Organs1
- These are masses of foamy macrophages ( cells that are part of the immune system ), multinucleated giant cells ( fused epithelioid cells ), and cholesterol clefts that produce thickened, dimpled skin with yellow-to-orange coloration and occur infrequently in internal organs. (ivis.org)
20161
- [ 1 ] Within the 2016 World Health Organization (WHO) category of "acute myeloid leukemia and related neoplasms," the related neoplasms derive from immature cells with evidence of myeloid differentiation, or from precursors of plasmacytoid dendritic cells. (medscape.com)
Secondary1
- Excessive friction and inflammation can cause skin breakdown and create an entry point for secondary fungal and bacterial infections, such as Candida , group A beta-hemolytic streptococcus, and Corynebacterium minutissimum . (aafp.org)
Diseases1
- A handout on this topic is available at https://familydoctor.org/familydoctor/en/diseases-conditions/intertrigo.html . (aafp.org)